ALKBH5抑制miR-29a-3p的表达,从而加剧与脊髓结核相关的炎症反应
Mengqi Zhu1,2, Zhengyong Tao1,2, XingYu Duan1,2
1Department of Orthopedic, General Hospital of Ningxia Medical University, Ningxia Hui Autonomous Region, No.804 Shengli Street, Yinchuan, 750004, China.
Journal of orthopaedic surgery and research
|August 21, 2025
概括
在脊柱结核病中,ALKBH5 抑制miR- 29a- 3p,促进炎症. 针对这种途径可能为脊柱结核提供新的治疗方法.
科学领域:
- 分子生物学
- RNA 修改
- 免疫学
背景情况:
- N6-甲基氨酸 (m6A) 是一种普遍存在的RNA修饰.
- 在脊柱结核病 (STB) 中m6A的作用尚不完全理解.
- 在STB患者中,miR- 29a- 3p的表达有所差异.
研究的目的:
- 在STB中研究ALKB同类5 (ALKBH5) 的miR-29a-3p调节.
- 阐明ALKBH5对STB炎症反应的影响机制.
主要方法:
- 来自STB患者和对照者的组织样本分析.
- qRT-PCR,免疫组织化学和免疫光测定ALKBH5和miR-29a-3p的表达.
- 为了验证监管机制,MeRIP,Western blot和ELISA进行了测试.
主要成果:
- 在STB中,ALKBH5上调,miR- 29a- 3p下调.
- 通过m6A修饰,ALKBH5直接向并抑制miR-29a-3p的成熟.
- 抑制miR- 29a- 3p促进了炎症因子 (TNF- α,IL- 1β,IL- 17A),而过度表达则抑制了它们.
结论:
- 在STB中抑制miR-29a-3p的表达.
- 这种抑制促进炎症因子的释放,有助于STB的发病.
- 通过ALKBH5调节miR-29a-3p是STB的潜在治疗点.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.7K
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
571
相关概念视频
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
